November 1, 2016
Advanced Oncotherapy sees board changes
Advanced Oncotherapy has announced that Lord David Evans has stepped down
Pharmaceuticals, Biotechnology and Life Sciences
Advanced Oncotherapy has announced that Lord David Evans has stepped down
Advanced Oncotherapy, the developer of proton therapy systems for cancer treatment, has appointed Professor Stephen Myers OBE, Head of Medical Applications at CERN, as Executive Chairman of its subsidiary ADAM S.A.